President Trump nominates Stephen Hahn as new FDA commissioner
President Donald Trump is expected to nominate Dr. Stephen Hahn to be the next head of the US Food and Drug Administration.
The acting commissioner of the FDA, Dr. Ned Sharpless, will return to his role as the director of the National Cancer Institute, according to a press release from the US Department of Health and Human Services.
By law, Sharpless was only allowed to serve a total of 210 days under the Federal Vacancies Reform Act. His tenure ended Friday at 5 p.m. ET.
Hahn is a well-known radiation oncology expert and is the current chief medical executive of The University of Texas MD Anderson Cancer Center in Houston, where has been a professor of radiation oncology since January 2015.
Asked to describe himself when he was appointed to the leadership position at MD Anderson, Hahn used one word: “Energetic.”
The agency protects public health by regulating much more than the food and drugs mentioned in the department’s name. The FDA regulates medical devices, tobacco, alcohol, veterinary products, vaccines, blood, microwave ovens, nail polish and much more.
MD Anderson is one of the world’s largest cancer centers. It is ranked No. 1 in the United States for cancer care, according to the U.S. News <><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><& World Report/a "Best Hospitals" survey./ppIt cares for more than 141,000 patients in 2018. It is known as a leading cancer research center, earning the most number of grants from the National Cancer Institute, according to the center. Its staff even includes a 2018 a href="https://www.nobelprize.org/prizes/medicine/2018/allison/facts/" target="_blank"Nobel Prize/a winner./ppAt MD Anderson, Hahn had a good reputation for turning its budget around. The center faced serious financial losses in 2016, according to the a href="https://www.houstonchronicle.com/news/houston-texas/houston/article/Aiding-an-ailing-hospital-10995382.php" target="_blank"Houston Chronicle/a. The paper said when Hahn noticed the problem, he "laid out a slide presentation to top officials that showed the elite Houston hospital was on track to lose up to $450 million in the new fiscal year without swift and decisive action."/pp"We were in a financial crisis, if you will, and that we had to move in a certain direction," Hahn told the a href="https://cancerletter.com/articles/20170303_1/" target="_blank"Cancer Letter /ain 2017 in an extensive interview about that time in his work. He oversaw the largest layoffs in the cancer center history, but the center moved back into solid financial territory./ppMoney challenges weren't the only test of Hahn's leadership. This year, when MD Anderson received notification from the Centers for Medicare and Medicaid Services that it could become ineligible for reimbursements a href="https://www.mdanderson.org/newsroom/statement-regarding-surveys-by-the-centers-for-medicare-and-medi.h00-159303834.html" target="_blank"after investigations/a found violations with its labs, Hahn publicly promised to fix the problems and took responsibility. MD Anderson explained that corrective action is ongoing, according a href="http://cdn.cnn.com/cnn/2019/images/10/24/corrective.action.md-anderson-medicare-poc-to-texas-hhsc.pdf" target="_blank"to a letter /aMD Anderson sent CMS./ppHahn was first brought to MD Anderson a href="https://www.ascopost.com/issues/october-15-2014/radiation-oncologist-stephen-hahn-md-to-join-md-anderson/" target="_blank"in 2015/a to run its radiation oncology division and was appointed chief medical executive in a href="https://www.linkedin.com/in/steve-hahn-4393348/" target="_blank"June 2018/a./ppBefore his work in Texas, Hahn was chairman of radiation oncology at the a href="https://www.med.upenn.edu/apps/faculty/index.php/g275/p2216" target="_blank"University of Pennsylvania/a School of Medicine from 2005 to 2014. As vice chairman for research, he led the expansion of the department's research base, which regularly ranked first or second for NIH funding, a href="https://www.pennmedicine.org/news/news-releases/2005/september/stephen-m-hahn-md-named-chair" target="_blank"according to the school/a./ppIn 2009, Hahn testified on Capitol Hill, taking responsibility for a doctor who worked for him who had botched the prostate cancer care of dozens of military veterans, according to a href="https://www.govinfo.gov/content/pkg/CHRG-111hhrg51875/html/CHRG-111hhrg51875.htm" target="_blank"Hahn's testimony/a. He asked the doctor to resign and created a new system to prevent future mistakes./ppAs a clinician, a href="https://www.astro.org/About-ASTRO/Board-and-Leadership/Board-of-Directors/bios/Stephen-M-Hahn" target="_blank"Hahn specialized/a in treating lung and genitourinary cancers. He is listed as an author on more than 200 peer-reviewed journal articles and other publications that focus on topics including proton therapy, radiotherapy and cost-effective treatments./ppIn the early 1990s, Hahn worked in Santa Rosa, California, as a medical and radiation oncologist, and took a leadership role early in his career as chief resident of internal medicine at the University of California, San Francisco. He worked from a href="http://globalrt.org/member/steve-hahn/" target="_blank"1993-1995/a in Bethesda, Maryland, as chief of the National Cancer Institute's prostate cancer clinic./ppHahn graduated with a bachelor's degree in biology from Rice University in 1980. He went to medical school in Philadelphia at Temple University, graduating in 1984./ppThe same year he graduated, Hahn married Lota Leigh Morning at the First Presbyterian Church of Allentown, according to the a href="https://webcache.googleusercontent.com/search?q=cache:xzUeKuzlZVsJ:https://www.mcall.com/news/mc-xpm-1984-06-10-2419053-story.html+cd=21hl=enct=clnk><><><><><><><><><><><><><><><><><>